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Synthesis and antitumor activity of some novel thiophene, 
pyrimidine, coumarin, pyrazole and pyridine derivatives
2-Cyano-N-(thiazol-2-yl) acetamide (2a) and 2-cyano-N-(oxazol-
2-yl) acetamide (2b) were obtained via the reaction of ethyl cya-
noacetate with either 2-aminothiazole (1a) or 2-aminooxazole 
(1b). The formed products were directed toward the reaction 
with cyclopentanone and elemental sulfur in the presence of 
triethylamine to give cyclopenta[b]thiophene derivatives (3a,b). 
The latter products were reacted with either ethyl cyanoacetate 
or malononitrile to form compounds 4a,b and 5a,b, respectively. 
Compounds 4a,b were aimed at synthesizing some heterocyclic 
compounds; thus internal cyclization reactions were intro-
duced to form compounds 6a,b. Also, compounds 4a,b reacted 
with salicylaldehyde, hydrazine derivatives and either urea or 
thiourea to produce coumarin derivatives (7a,b), pyrazole de-
rivatives (8a-d) and pyrimidine derivatives (9a-d), respectively. 
Reaction of either benzaldehyde or benzene diazonium chlo-
ride (11) with compounds 4a,b afforded compounds 10a,b and 
12a,b, respectively. On the other hand, compounds 5a,b under-
went internal cyclization to form pyrimidine derivatives 13a,b. 
Also, when compounds 5a,b reacted with either ethyl cyanoac-
etate or malononitrile, they gave pyridine derivatives (15a-d) 
through the formation of intermediates (14a-d). Finally, forma-
tion of fused pyrimidine derivatives (17a,b) was achieved 
through the reaction of compounds 5a,b and salicylaldehyde 
applying two different pathways. The first pathway used a cata-
lytic amount of piperidine to form compounds 16a,b; the latter 
products underwent cyclization to give compounds 17a,b. The 
second pathway, using a catalytic amount of sodium ethoxide 
solution directly in one step, afforded compounds 17a,b. Struc-
tures of the newly synthesized compounds were established 
using IR, 1H NMR, 13C NMR and mass spectrometry and their 
antitumor activity was investigated. Some of these compounds 
showed promising inhibitory effects on three different cell 
lines. However, fused pyrimidine acetonitrile derivatives 6a 
and 6b exerted the highest inhibitory effect, comparable to that 
of doxorubicin.
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Amino-thiophene derivatives were shown to be one of the most important groups of 
heterocyclic compounds with a wide spectrum of biological activities such as antitumor 
(1), antimitotic (2) and antiviral (3), in addition to either thiazol-amide with fungicidal ac-
tivity (4) or oxazole-amide with antimicrobial activity (5). Furthermore, thieno[2,3-d]pyri-
midine derivatives show antibacterial (6) and antiproliferative activity (7). Also, chromene- 
-3-carboxamide acts as an anti-Helicobacter pylori agent (8) and pyrazole derivatives have a 
specific effect with favorable antitumor activity (9). In addition, pyridine derivatives show 
anticonvulsant and anti-inflammatory (10), potential antitubercular (11) and anticonvul-
sant activity (12), among others.
In this article, we have described the synthesis of new heterocyclic compounds, thio-
phene, pyrimidine, coumarin, pyrazole and pyridine derivatives, in an attempt to improve 
the antitumor activity against three different cell lines: MCF-7 (breast adenocarcinoma), 
NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer).
EXPERIMENTAL
Melting points were determined in open capillaries and are not corrected. A Yanaco 
CHN CORDER MT-6 elemental analyzer (Japan) was used. IR spectra were recorded in 
KBr pellets using a PA-9721 IR spectrophotometer (Shimadzu, Japan). A Jeol 300 MHz 
(Japan) instrument was used to record the 1H NMR and 13C NMR spectra. CD3SOCD3 was 
used as a solvent and TMS as internal standard. Chemical shifts were expressed as δ (ppm). 
Kratos (75 eV) MS equipment (Germany) was used for mass spectra recording.
The synthetic pathways used are represented in Schemes 1–4 while the physicochem-
ical and spectral data of the newly synthesized compounds are given in Tables I and II.
Syntheses
2-Cyano-N-(thiazol-2-yl)acetamide (2a) and 2-cyano-N-(oxazol-2-yl)acetamide (2b). – To a 
solution of either 2-aminothiazole (1a) (5.007 g, 0.05 mol) or 2-aminooxazole (1b) (4.204 g, 












































a X = S
b X = O
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Scheme 2
ethyl cyanoacetate (5.656 g, 0.05 mol) was added and the reaction mixture was heated 
under reflux for 3 h, cooled and poured onto ice. Conc. HCl (a few drops) was added. The 
formed precipitate was filtered out and recrystallized from 1,4 dioxane to afford the de-
sired product.
2-Amino-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (3a) and 
2-amino-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (3b). – To a so-
lution of either compound 2a (5.016 g, 0.03 mol) or 2b (4.534 g, 0.03 mol) in 50 mL of absolute 
EtOH containing triethylamine (1.0 mL), cyclopentanone (2.524g, 0.03 mol) and elemental 
sulfur (0.96 g, 0.03 mol) were added. The whole reaction mixture was heated under reflux 
for 2 h, then poured into an ice/water mixture containing a few drops of concentrated 
hydrochloric acid and the formed solid product, in each case, was collected by filtration 
















































a  X = S, Y = O
b  X = O, Y = O
c  X = S, Y = S
d  X = O, Y = S
a  X = S, R = H
b  X = O, R = H
c  X = S, R = Ph
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amide (4a) and 2-(2-cyanoacetamido)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-
carboxamide (4b). – To a solution of either compound 3a (5.307 g, 0.02 mol) or 3b (4.986 g, 0.02 
mol) in 1,4-dioxane (50 mL) containing triethylamine (0.5 mL), ethyl cyanoacetate (2.262 g, 
0.02 mol) was added. The resulting reaction mixture was heated under reflux for 3 h, 
cooled and poured into an ice/water mixture with a few drops of conc. HCl added. The 
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a, X = S, Y = CN
b, X = O, Y = CN
c, X = S, Y = COOEt
d, X = O, Y = COOEt
a, X = S, Y = NH2
b, X = O, Y = NH2
c, X = S, Y = OH
d, X = O, Y = OH
a, X = S
b, X = O
a, X = S
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2-(1-Amino-2-cyanoethylideneamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thio-
phene-3-carboxamide (5a) and 2-(1-amino-2-cyanoethylideneamino)-N-(oxazol-2-yl)-5,6-dihydro-
4H-cyclopenta[b]thiophene-3-carboxamide (5b). – To a solution of either compound 3a (2.654 
g, 0.01 mol) or 3b (2.493 g, 0.01 mol) in 1,4-dioxane (40 mL) containing triethylamine (0.5 
mL), malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under 
reflux for 2 h, cooled and poured into an ice/water mixture containing a few drops of conc. 
HCl. The formed precipitate was filtered out and recrystallized from absolute ethanol.
2-(4-Oxo-3-(thiazol-2-yl)-3,4,6,7-tetrahydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-
yl)acetonitrile (6a) and 2-(4-oxo-3-(oxazol-2-yl)-3,4,6,7-tetrahydro-5H-cyclopenta[4,5]thieno-
[2,3-d]pyrimidin-2-yl)acetonitrile (6b). – A suspension of either 4a (0.665 g, 0.002 mol) or 4b 
(0.633 g, 0.002 mol) in sodium ethoxide (0.002 mol) [prepared by dissolving elemental so-
dium (0.046 g, 0.002 mol) in abs. EtOH (40 mL)] was heated over a boiling water bath for 6 
h and then left to cool. The solid product formed upon pouring onto ice/water containing 
a few drops of hydrochloric acid (10 %) (until pH = 6). It was collected by filtration and then 
recrystallized from absolute ethanol.
N-(3-(thiazol-2-yl-carbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl-2-oxo-2H-
chromene-3-carboxamide (7a) and N-(3-(oxazol-2-yl-carbamoyl)-5,6-dihydro-4H-cyclopenta[b]
thiophen-2-yl)-2-oxo-2H-chromene-3-carboxamide (7b). – To a solution of either compound 4a 
(0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) in 1,4-dioxane (40 mL) containing piperidine 
(0.50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. The reaction mixture was heated 
under reflux for 6 h and then evaporated under vacuum. The remaining product was 
triturated with absolute ethanol and the formed solid product was collected by filtration 
and recrystallized from 1,4-dioxane.
2-(5-Amino-1H-pyrazol-3-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophe-
ne-3-carboxamide (8a), 2-(5-amino-1H-pyrazol-3-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cy-
clo penta[b]thiophene-3-carboxamide (8b), 2-(5-amino-1-phenyl-1H-pyrazol-3-ylamino)-N-(thia-
zol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (8c) and 2-(5-amino-1-phenyl-
1H-pyrazol-3-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide 
(8d). – Either compound 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) was dissolved in 
absolute ethanol (50 mL) containing piperidine (0.50 mL), hydrazine hydrate (0.1 g, 0.002 
mol) or phenylhydrazine (0.216 g, 0.002 mol) and the whole mixture was refluxed for 3 h 
and then poured into water containing ice and a few drops of concentrated HCl. Suction 
filtration was then used to collect the coagulated precipitate; the formed solid product was 
recrystallized from ethanol.
2-(6-Amino-2-oxo-2,5-dihydropyrimidin-4-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclo- 




cyclopenta[b]thiophene-3-carboxamide (9d). – To a suspension of either compound 4a (0.665 g, 
0.002 mol) or 4b (0.633 g, 0.002 mol) in sodium ethoxide (0.002 mol, 50 mL), either urea (0.12 g, 
0.002 mol) or thiourea (0.152 g, 0.002 mol) was added. The whole reaction mixture was 
heated over a boiling water bath for 3 h, then poured onto ice/water containing a few drops 
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of concentrated hydrochloric acid (until pH 6) and the solid product was collected by filtra-
tion and recrystallized from absolute ethanol.
2-(2-Cyano-3-phenylacrylamido)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-
3-carboxamide (10a) and 2-(2-cyano-3-phenylacrylamido)-N-(oxazol-2-yl)-5,6-dihydro-4H-cy-
clopenta[b]thiophene-3-carboxamide (10b). – Either compound 4a (0.665 g, 0.002 mol) or 4b 
(0.633 g, 0.002 mol) was dissolved in 50 mL abs. EtOH with added piperidine (0.50 mL). 
Benzaldehyde (0.21 g, 0.002 mol) was added and the reaction mixture was heated under 
reflux for 3 h and then poured into ice-containing water with a few drops of conc. HCl 
added. The coagulated precipitate was collected by suction filtration and recrystallized 
from 1,4-dioxane.
2-(3-(Thiazol-2-yl-carbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-ylamino)-2-oxo-N’-
phenylacetohydrazonoyl cyanide (12a) and 2-(3-(oxazol-2-ylcarbamoyl)-5,6-dihydro-4H-cy clo-
penta[b]thiophen-2-ylamino)-2-oxo-N’-phenylacetohydrazonoyl cyanide (12b). – To a cold solu-
tion (0–5 °C) of either compound 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) in abs. 
ethanol (50 mL) containing sodium hydroxide (0.08 g, 0.002 mol), benzenediazonium chlo-
ride (11) (0.002 mol) [prepared by adding an aqueous sodium nitrite solution (0.138 g, 0.002 
mol) to a cold solution of aniline (0.002 mol) with an appropriate amount of concentrated 
HCl, at 0–5 °C, with continuous stirring] was added under continuous stirring. The reac-
tion mixture was stirred at room temperature for an additional 4 h and the solid product 
so formed was collected by filtration and recrystallized from 1,4-dioxane.
2-(4-(Aminothiazol-2-yl)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl) aceto-
nitrile (13a) and 2-(4-(amino-oxazol-2-yl)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-
2-yl)acetonitrile (13b). – A suspension of either 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 
mol) in sodium ethoxide (50 mL, 0.002 mol) was heated over a boiling water bath for 6 h 
and then left to cool. The solid product was formed upon pouring it into ice/water contain-
ing a few drops of concentrated hydrochloric acid (until pH = 6); it was collected by filtra-




din-2-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (15c) and 
2-(4-amino-5-cyano-6-hydroxypyridine-2-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-
cyclopenta[b]thiophene-3-carboxamide (15d). – To a suspension of either 5a (0.663 g, 0.002 mol) 
or 5b (0.631 g, 0.002 mol) in sodium ethoxide (0.002 mol, 50 mL), either ethyl cyanoacetate 
(0.226 g, 0.002 mol) or malononitrile (0.132 g, 0.002 mol) was added. The reaction mixture 
was heated under reflux for 3 h. It was then poured onto an ice/water mixture containing 
a few drops of concentrated hydrochloric acid. The formed solid product was collected by 
filtration and recrystallized from absolute ethanol.
2-(Amino(2-oxo-2H-chromen-3-yl)methyleneamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-
cyclopenta[b]thiophene-3-carboxamide (16a) and 2-(amino(2-oxo-2H-chromen-3-yl)-methyl ene-
amino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (16b). – To a so-
lution of either compound 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 mol) in 1,4-dioxane 
(40 mL) containing piperidine (0.50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. The 
reaction mixture was heated under reflux for 4 h and then evaporated under vacuum. The 
28
M. Albratty et al.: Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine deriva-
tives, Acta Pharm. 67 (2017) 15–33.
 
remaining product was triturated with absolute ethanol and the crude solid product was 
collected by filtration and recrystallized from 1,4-dioxane.
4-(2-Amino-thiazol-2-yl)-2-(2-oxo-2H-chromene-3-yl)-6,7-dihydro-5H-cyclopenta[4,5]
thieno[2,3-d]pyrimidine (17a) and 4-(2-aminooxazol-2-yl)-2-(2-oxo-2H-chromene-3-yl)-6,7-dihy-
dro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine (17b). – Method A. A solution of either com-
pound 16a (0.872 g, 0.002 mol) or 16b (0.84 g, 0.002 mol) in dimethylformamide (40 mL) 
containing a catalytic amount of triethylamine (0.5 mL) was heated under reflux for 3 h. It 
was then poured into an ice/water mixture containing a few drops of conc. HCl. The 
formed solid product was collected by filtration and recrystallized from 1,4-dioxane.
Method B. To a solution of either compound 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 
mol) in sodium ethoxide (0.002 mol, 50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. 
The reaction mixture was heated under reflux for 4 h and then evaporated under vacuum. 
The remaining product was triturated with absolute ethanol and the solid product so 
formed was collected by filtration and recrystallized from 1,4-dioxane.
Antitumor activity tests: materials and methods
Fetal bovine serum (FBS) and L-glutamine were purchased from Gibco Invitrogen Co. 
(UK) while RPMI-1640 medium was from Cambrex (USA). Dimethyl sulfoxide (DMSO), 
doxorubicin, streptomycin, penicillin and sulforhodamine B (SRB) were all from Sigma 
Chemical Co. (USA).
Three different human tumor cell lines were used: MCF-7 (breast adenocarcinoma), 
NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer). MCF-7 was obtained from 
the European Collection of Cell Cultures (ECACC, Salisbury, UK) while NCI-H460, SF-268 
and normal fibroblast cells (WI-38) were kindly donated by the National Cancer Institute 
(NCI, Cairo, Egypt).
Cell lines grew as monolayers and were routinely maintained in RPMI-1640 medium 
supplemented with 5 % heat-inactivated FBS, 2 mmol L–1 glutamine and antibiotics (peni-
cillin 100 U mL–1 and streptomycin 100 mg mL–1), at 37 oC in a humidified atmosphere 
containing 5 % CO2. Exponentially growing cells were obtained by plating 1.5 × 105 cell 
mL–1 for MCF-7 and SF-268 and 0.75 × 104 cell mL–1 for NCI-H460. This was followed by 24-h 
incubation. The influence of DMSO as a solvent on the growth of cell lines was evaluated 
in all experiments. It was performed by exposing untreated control cells to the maximum 
concentration of DMSO used in each assay (0.5 %).
The in vitro tumor cell growth assay was performed according to the procedure de-
scribed by the National Cancer Institute (USA) (13). This method uses the protein-binding 
dye sulforhodamine B to indicate cell growth. Afterwards, exponentially growing cells in 
96-well plates were exposed to five serial dilutions of each compound, starting from a 
maximum concentration of 150 mmol L–1 for 48 h. Following this exposure period, adher-
ent cells were fixed, washed and stained. The bound stain was then dissolved in DMSO 
and absorbance was measured at 492 nm in a plate reader (Power wave XS, Bio-Tek Instru-
ments, USA). For each test compound and cell line, a dose-dependent curve was estab-
lished. GI50 (concentration of the compound that inhibits 50 % of net cell growth) was cal-
culated (14). Doxorubicin was used as a reference drug (positive control).
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Syntheses of the new heterocyclic compounds, thiophene, pyrimidine, coumarin, pyr-
azole and pyridine derivatives, are depicted in Schemes 1–4. Elucidation of their structures 
was based on analytical and spectral data.
Synthesis of compounds 2a,b-4a,b and 5a,b is displayed in Scheme 1. The reaction of 
ethyl cyanoacetate with either 2-aminothiazole (1a) or 2-aminoxazole (1b) yielded the acet-
amido derivative of each thiazole and oxazole ring (2a,b), respectively. The latter, upon 
reaction with cyclopentanone in the presence of elemental sulfur and a catalytic amount 
of triethylamine, gave thiophene derivatives 3a,b, which were directed toward the reaction 
with either ethyl cyanoacetate or malononitrile, and yielded two pairs of carboxamide 
derivatives 4a,b and 5a,b, respectively.
Reactivity of the first pair of carboxamide derivatives 4a,b was studied through some 
different types of reactions. Thus, internal cyclization was introduced to give fused py-
rimidine derivatives 6a,b. The structure of compounds 6a,b was verified by elemental 
analysis and spectral data. In compound 6a, the 1H NMR spectrum indicated the presence 
of a multiplet at δ 1.96–2.08 ppm, which could be assigned to 3 CH2 groups. A singlet at δ 
3.08–3.12 ppm indicated the presence of the CH2 side group and a multiplet at δ 6.62–6.73 
ppm corresponded to 2 H of the thiazole ring. The IR spectrum of compound 6a showed 
disappearance of 2 NH stretching signals. Compounds 4a,b also reacted with salicylalde-
hyde in the presence of piperidine to form coumarin derivatives 7a,b. For compound 7a, 
the 1H NMR spectrum showed a multiplet at δ 1.79–1.86 ppm from the presence of 3 CH2 
groups, a multiplet at δ 6.65–6.75 ppm corresponding to 2 H of the thiazole ring, a singlet 
at δ 6.88 ppm corresponding to 1H of the coumarin ring, a multiplet at δ 7.34–7.49 ppm 
corresponding to 4 H of the benzene ring and two singlets, D2O-exchangeable at δ 8.39 and 
8.56 ppm corresponding to 2 H of 2 NH groups. Furthermore, the reaction of compounds 
4a,b with either hydrazine hydrate or phenylhydrazine afforded compounds 8a-d. Py-
rimidine derivatives 9a-d were obtained through the reaction of compounds 4a,b with 
either urea or thiourea in sodium ethoxide. 1H NMR spectrum of compound 9a showed a 
multiplet at δ 1.83–1.94 ppm that indicated 3 CH2 groups, a singlet at δ 3.96 ppm corre-
sponding to 2 H of the pyrimidine ring, a singlet, D2O-exchangeable at δ 4.51 ppm corre-
sponding to 2 H of the amino group, a multiplet at δ 6.61–6.68 ppm corresponding to 2 H 
of the thiazole ring and two singlets, D2O-exchangeable at δ 8.53 and 8.71 ppm correspond-
ing to 2 H of 2 NH groups. In the reaction of compounds 4a,b with either benzaldehyde or 
benzenediazonium chloride (11), compounds 10a,b and 12a,b were formed, respectively. 
1H NMR spectrum of compound 10a indicated a multiplet at δ 1.83–1.96 ppm which repre-
sented 3 CH2 groups, a singlet at δ 5.18 ppm corresponding to 1 H of =CH group, a multi-
plet at δ 6.33–6.58 ppm corresponding to 2 H of the thiazole ring, a multiplet at δ 7.35–7.48 
ppm corresponding to 5 H of the benzene ring and two singlets, D2O-exchangeable at δ 
8.37 and 8.52 ppm corresponding to 2 H of 2 NH groups.
Also, reactivity of the second pair of carboxamide derivatives 5a,b was used. They 
underwent ready cyclization when heated in a sodium ethoxide solution, leading to the 
corresponding pyrimidine derivatives 13a,b. Thus, the 1H NMR spectrum of compound 
13a showed a multiplet at δ 1.76–1.85 ppm from the 3 CH2 groups, a singlet at δ 3.12–3.19 
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ppm that indicated the presence of the CH2 side group, a multiplet at δ 6.51–6.63 ppm cor-
responding to 2 H of the thiazole ring and a singlet D2O-exchangeable at δ 8.11 ppm cor-
responding to 1 H of the NH group. Moreover, 13C NMR of the same compound showed 
signals at 21.2, 22.8, 25.4, 38.2 (cyclopentyl C, CH2 side group), 121.4 (CN), 123.1, 125.4, 127.3, 
130.4, 132.9, 138.6, 143.3, 146.4 ppm (thiophene C, thiazole C, pyrimidine C). Furthermore, 
when compounds 5a,b reacted with either ethyl cyanoacetate or malononitrile in sodium 
ethoxide, they formed pyridine derivatives 15a-d, through the formation of intermediate 
compounds 14a-d. 1H NMR spectrum of 15a showed a multiplet at δ 1.81–1.93 ppm assign-
able to 3 CH2 groups, two singlets D2O-exchangeable at δ 4.33 and 4.52 ppm that indicated 
the presence of 4 H of 2 NH2 groups, a multiplet at δ 6.61–6.78 ppm corresponding to 2 H 
of the thiazole ring and 1 H of the pyridine ring and two singlets D2O-exchangeable at δ 
8.53 and 8.91 ppm indicating the presence of 2 H for 2 NH groups. Finally, the reaction of 
5a,b with salicylaldehyde took two specific pathways. The first was carried out in piperi-
dine affording compounds 16a,b. The other products underwent cyclization to form fused 
pyrimidine derivatives 17a,b in dimethylformamide. The second pathway took place in a 
sodium ethoxide solution to form compounds 17a,b directly. The analytical and spectral 
data of products 16a,b and 17a,b are consistent with the assigned structures.
Effects on the growth of human tumor cell lines and QSAR
Compounds 2a,b-17a,b were examined for their inhibitory effect on the in vitro growth 
of human tumor cell lines of different tumor types, namely, breast adenocarcinoma (MCF-
7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268). All tested compounds 
inhibited the growth of the tested tumor cell lines in a dose-dependent manner (data not 
shown). The results from Table III show that fused pyrimidine acetonitrile derivatives 6a,b 
exerted the highest inhibitory effect against all three tumor cell lines, comparable with the 
reference standard. Among the fused pyrimidine derivatives containing coumarin moiety, 
compounds 17a,b showed the highest inhibitory effects against all three tumor cell lines. 
Compounds 2a,b, 13a,b and 15a,b,c,d showed moderate inhibitory effects against all three 
cancer cell lines, while the rest of the compounds (3a,b, 4a,b, 5a,b, 7a,b, 8a-d, 9a-d, 10a,b, 
12a,b and 16a,b) showed low effects.
When comparing fused pyrimidine acetonitrile derivatives, it was found that com-
pound 6b was slightly more effective than 6a, possibly due to the presence of the oxazole 
ring in 6b instead of the thiazole ring in 6a. On the other hand, for the fused pyrimidine 
derivatives containing coumarin moiety, it was found that compound 17a with the thiazole 
ring showed stronger effect than compound 17b containing the oxazole ring. Cyanoacet-
amide derivatives 2a and 2b showed comparable effects in the presence of the thiazole ring 
in compound 2a instead of oxazole ring in compound 2b. The same was seen when compar-
ing fused pyrimidine derivatives, 13a with the thiazole ring and 13b with the oxazole ring. 
Among pyridine derivatives 15a-d, compound 15a was most effective against all three cell 
lines, possibly due to the presence of the NH2 group instead of OH group (in 15c and 15d), 
in addition to the presence of the thiazole ring instead of the oxazole ring (in 15b).
When comparing the amino-thiophene derivatives 3a,b, acetamido-thiophene deriva-
tives 4a,b and acetimido-thiophene derivatives 5a,b, it was found that these compounds 
showed almost the same effects despite structural differences (namely, the presence of 
NH2 in 3a,b, CNCH2CONH in 4a,b and CNCH2C=N(NH2) in 5a,b). On the other hand, 
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Table III. Effect of compounds 2a,b-17a,b on the growth of three human tumor cell lines
Compd.
GI50 (mmol L–1)a
MCF-7 NCI-H460 SF-268 WI-38
2a 23.7 ± 7.4 24.1 ± 5.3 28.5 ± 5.9 NA
2b 27.1 ± 8.9 25.7 ± 6.8 26.2 ± 4.9 NA
3a 44.6 ± 7.8 45.1 ± 7.3 44.3 ± 7.7 65.5 ± 11.7
3b 41.9 ± 7.9 48.7 ± 6.3 42 ± 8.3 NA
4a 51.3 ± 11.8 50.4 ± 10.1 49.5 ± 11.5 > 100
4b 44.2 ± 9.3 46.1 ± 9.3 47.5 ± 9.5 > 100
5a 48.0 ± 9.9 48.2 ± 10.7 44.7 ± 9.5 > 100
5b 41.8 ± 7.6 43.5 ± 6.5 43.5 ± 8.1 38.1 ± 12.5
6a 0.1 ± 0.08 0.25 ± 0.4 1.6 ± 0.3 15.1 ± 8.3 
6b 0.09 ± 0.06 0.07 ± 0.03 1.3 ± 0.2 14.4 ± 7.6 
7a 37.9 ± 9.5 36.4 ± 8.7 32.1 ± 6.8 22.7 ± 11.3
7b 39.3 ±10.2 34.6 ± 8.8 37.9 ± 9.7 49.1 ± 14.4
8a 40.3 ± 5.4 41.1 ± 7.6 36.6 ± 8.6 28.3 ± 12.3
8b 33.1 ± 7.2 34.5 ± 5.9 35.3 ± 6.2 21.1 ± 13.5
8c 29.0 ± 6.9 30.0 ± 7.4 27.5 ± 10.8 22.6 ± 11.5
8d 35.9 ± 11.3 39.2 ± 122 36.0 ± 14.1 23.1 ± 14.8
9a 44.2 ± 7.3 46.6 ± 6.4 34.9 ± 19.1 12.7 ± 11.8
9b 34.9 ± 11.2 41.0 ± 8.8 44.5 ± 11.6 29.3 ± 10.1
9c 36.7 ± 6.9 40.9 ± 6.6 42.4 ± 9.3 NA
9d 41.2 ± 8.6 34.0 ± 6.9 39.7 ± 8.7 NA
10a 42.7 ± 13.9 39.9 ± 14.3 32.3 ± 5.3 NA
10b 39.2 ± 6.8 37.3 ± 6.4 35.9 ± 6.9 NA
12a 45.2 ± 12.8 47.1 ± 16.4 38.5 ± 21.1 NA
12b 38.4 ± 7.7 35.2 ± 8.3 37.6 ± 8.9 NA
13a 21.7 ± 6.9 17.9 ± 4.7 21.5 ± 5.3 > 100
13b 21.2 ± 5.6 18.0 ± 3.9 19.7 ± 4.9 > 100
15a 16.2 ± 6.9 17.3 ± 7.8 15.1 ± 9.9 > 100
15b 25.2 ± 6.8 25.3 ± 9.4 26.9 ± 11.9 > 100
15c 19.9 ± 12.8 23.1 ± 11.4 30.2 ± 15.3 > 100
15d 20.2 ± 6.3 27.1 ± 8.3 25.5 ± 9.5 > 100
16a 41.1 ± 14.8 43.3 ± 16.4 39.8 ± 6.9 NA
16b 39.7 ± 8.5 37.4 ± 9.9 32.6 ± 10.5 NA
17a 3.1 ± 0.09 2.3 ± 1.4 2.9 ± 1.1 > 100
17b 6.2 ± 1.4 3.4 ± 0.7 4.8 ± 0.9 > 100
Doxorubicin 0.04 ± 0.008 0.09 ± 0.008 0.09 ± 0.007 > 100
NA – not applicable
Results are given in concentrations that were able to cause 50 % of cell growth inhibition (GI50) after a continuous 
exposure for 48 h.
a Mean ± SEM of three-independent experiments performed in duplicate.
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when comparing coumarin derivatives 7a,b, pyrazole derivatives 8a-d and pyrimidine 
derivatives 9a-d, it was found that compound 8c was highly effective. This may be due to 
the presence of the pyrazole ring instead of either coumarin ring in compounds 7a,b or 
pyrimidine ring in compounds 9a-d, in addition to the phenyl group instead of H (in 8a,b) 
and thiazole ring instead of oxazole ring (in 8d).
Finally, when comparing benzylidine derivatives 10a,b, phenylhydrazone derivatives 
12a,b and coumarin derivatives 16a,b, it was found that these compounds may be of almost 
the same efficacy despite the presence of the benzylidine side chain in compounds 10a,b, 
phenylhydrazo side chain in compounds 12a,b and coumarin moiety in compounds 16a,b.
CONCLUSIONS
Among the newly synthesized products, fused pyrimidine acetonitrile derivatives 6a 
and 6b showed high inhibitory activity against all the three tumor cell lines, MCF-7, NCI-
H460 and SF-268, comparable to that of doxorubicine They were followed by fused py-
rimidine derivatives containing the coumarin moiety, 17a and 17b.
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